[51 FR 26364, July 22, 1986, as amended at 63 FR 4572, Jan. 30, 1998; 73 FR 34859, June 19, 2008; 76 FR 31470, June 1, 2011; 79
FR 68115, Nov. 14, 2014; 83 FR 7387, Feb. 21, 2018; 87 FR 2045, Jan. 13, 2022]
(1)
FDA will give the public notice of an order denying approval of the PMA. The notice will be placed on
the FDA's home page on the Internet (http://www.fda.gov), and it will state that a detailed summary of
information respecting the safety and effectiveness of the device, including information about any
adverse effects of the device on health, is available on the Internet and has been placed on public
display and that copies are available upon request. When a notice of denial of approval is made
publicly available, data and information in the PMA file will be available for public disclosure in
accordance with ยง 814.9.
(2)
A request for copies of the current PMA approvals and denials document and copies of summaries
of safety and effectiveness shall be sent in writing to the Freedom of Information Staff's address
listed on the Agency's Web site at http://www.fda.gov.
(e)
FDA will issue an order denying approval of a PMA after an approvable or not approvable letter has been
sent and the applicant:
(1)
Submits a requested amendment but any ground for denying approval of the application under
section 515(d)(2) of the act still applies; or
(2)
Notifies FDA in writing that the requested amendment will not be submitted; or
(3)
Petitions for review under section 515(d)(4) of the act by filing a petition in the form of a petition for
reconsideration under ยง 10.33.
21 CFR 814.45 (up to date as of 5/22/2025)
Denial of approval of a PMA.
21 CFR 814.45(d)(1)
21 CFR 814.45(e)(3) (enhanced display)
page 2 of 2